DGAP-Adhoc: STADA: Helmut Kraft named Chief Financial Officer

STADA Arzneimittel AG / Change of Personnel

29.10.2009 

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Bad Vilbel, October 29, 2009 - Helmut Kraft (49) will be the new Chief
Financial Officer of STADA Arzneimittel AG. An agreement to that effect has
been completed today. The Supervisory Board will appoint Kraft to the
Executive Board effective January 1, 2010 for a three-year term.

Kraft, a trained attorney, has, since 1996, been working as Head of Group
Finance, Taxes and Investments at the PHOENIX group, a leading European
pharmaceutical wholesaler. His current areas of responsibility also include
General Management of several holding and finance companies as well as the
PHOENIX group's IT services provider. Prior to that, Kraft worked at Landis
& Gyr Holding GmbH (Siemens Building Technologies) as Head of Finance and
Taxes and at KPMG Deutsche Treuhand-Gesellschaft, Aktiengesellschaft,
Wirtschaftsprüfungsgesellschaft as an audit and tax assistant.

As of January 1, 2010, the Executive Board of STADA Arzneimittel AG thus
consists of Hartmut Retzlaff, Chairman of the Executive Board, Helmut
Kraft, Chief Financial Officer and Christof Schumann, Chief Production and
Development Officer.

Kraft succeeds Wolfgang Jeblonski, who left the Executive Board of STADA
Arzneimittel AG effective August 12, 2009 (see the Company's ad hoc release
of August 12, 2009).

Further information:
STADA Arzneimittel AG / Corporate Communications / Stadastraße 2-18 /
D61118 Bad Vilbel /
Phone: +49 (0) 6101 603-113 / Fax: +49 (0) 6101 603-506 / 
E-Mail: communications@stada.de
Or visit our website at www.stada.com.


29.10.2009  |[![CDATA[|[a href="http://www.dgap.de"|]Financial News transmitted by DGAP|[/a|]]]|]

---------------------------------------------------------------------------
 
Language:     English
Company:      STADA Arzneimittel AG
              Stadastraße 2-18
              61118 Bad Vilbel
              Deutschland
Phone:        +49 (0)6101 603- 113
Fax:          +49 (0)6101 603- 506
E-mail:       communications@stada.de
Internet:     www.stada.de
ISIN:         DE0007251803, DE0007251845, 
WKN:          725180, 725184, 
Indices:      MDAX
Listed:       Regulierter Markt in Frankfurt (Prime Standard), Düsseldorf;
              Freiverkehr in Berlin, Hannover, München, Hamburg, Stuttgart
 
End of News                                     DGAP News-Service
 
---------------------------------------------------------------------------